Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

NCT06855498 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Hidradenitis Suppurativa (HS)

Interventions

DRUG: povorcitinib

Sponsor

Incyte Corporation